Omnaris

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Ciclesonide 50ug (per actuation)

Commercializzato da:

Chiesi New Zealand Limited t/a Emerge Health

INN (Nome Internazionale):

Ciclesonide 50 µg (per actuation)

Dosaggio:

50 mcg/dose

Forma farmaceutica:

Nasal spray solution

Composizione:

Active: Ciclesonide 50ug (per actuation) Excipient: Carmellose sodium Disodium edetate Hydrochloric acid Hypromellose Microcrystalline cellulose Nitrogen Potassium sorbate Purified water

Confezione:

Inhaler, metered, Glass bottle with metered dose pump, 60 dose units

Classe:

Prescription

Tipo di ricetta:

Prescription

Prodotto da:

Dynamit Nobel GmbH

Indicazioni terapeutiche:

Omnaris® Nasal Spray is indicated for the treatment of seasonal allergic rhinitis in adults and children 6 years of age and older.

Dettagli prodotto:

Package - Contents - Shelf Life: Inhaler, metered, Glass bottle with metered dose pump - 60 dose units - 2 years from date of manufacture stored at or below 30°C. Unopened 4 months opened, Not Specified - Inhaler, metered, Glass bottle with metered dose pump - 120 dose units - 2 years from date of manufacture stored at or below 30°C. Unopened 4 months opened, Not Specified

Data dell'autorizzazione:

2010-06-28